3.4.21.20 4T1 cell murine breast adenocarcinoma cell line -, 691617 3.4.21.20 artery wall the enzyme is expressed in intimal and medial cells, particularly abundant in atheroma plaque 665909 3.4.21.20 B-cell - 683531 3.4.21.20 B-lymphoblastoid cell - 709987 3.4.21.20 B-lymphocyte - 665912, 709987 3.4.21.20 blood - 691629 3.4.21.20 blood plasma - 731354 3.4.21.20 breast adenocarcinoma cell line C166 cells 707965 3.4.21.20 breast adenocarcinoma cell line C166 tumor cells 709904 3.4.21.20 bronchoalveolar lavage - 708407 3.4.21.20 cardiomyocyte - 683354 3.4.21.20 carotid artery - 665909 3.4.21.20 Cl-66 cell mammary tumor cell 691629 3.4.21.20 Cl-66 cell murine breast adenocarcinoma cell line -, 691617 3.4.21.20 Cl-66M2 cell breast adenocarcinoma cell line 691629 3.4.21.20 Cl-66M2 cell murine breast adenocarcinoma cell line -, 691617 3.4.21.20 colon - 707047 3.4.21.20 commercial preparation - 649568 3.4.21.20 commercial preparation from leukocytes 653984 3.4.21.20 commercial preparation from neutrophils 683071, 684056 3.4.21.20 dendritic cell - 683531, 691695 3.4.21.20 dermal microvascular endothelial cell - 752917 3.4.21.20 endothelial cell - 731354 3.4.21.20 feces - 707047 3.4.21.20 HaCaT cell - 753400 3.4.21.20 heart - 683354 3.4.21.20 kidney - 683724 3.4.21.20 kidney healthy and ischemic 683042 3.4.21.20 leukocyte - 36500, 36512, 36517, 36518, 36520, 36521, 36522, 650266, 650552, 653984, 684082, 731422 3.4.21.20 leukocyte from patients with myeloid leukemia 36515 3.4.21.20 leukocyte neutrophil 36514, 36515, 36519 3.4.21.20 lung - 683957 3.4.21.20 lymphocyte - 690634 3.4.21.20 macrophage - 653667, 731354 3.4.21.20 mast cell - 653667, 664806 3.4.21.20 MCF-7 cell - 664512 3.4.21.20 microglia - 683531, 709987 3.4.21.20 monocyte - 651320, 683748, 684056, 709987 3.4.21.20 monocyte enzyme synthesis 683193 3.4.21.20 monocyte Mycobacterium tuberculosis infection results in a cathepsin switch with down-regulation of cathepsin G rendering Mycobacterium tuberculosis bacilli more viable. Downregulation of cathepsin G in macrophages is advantageous to Mycobacterium tuberculosis bacilli and possibly is an important mechanism by which Mycobacterium tuberculosis is able to evade the host immune defense 665169 3.4.21.20 additional information no activity in HeLa cells 653667 3.4.21.20 muscle - 752917 3.4.21.20 myeloid cell line myeloid dendritic cell1 and myeloid dendritic cell2 709987 3.4.21.20 myocyte - 683354 3.4.21.20 natural killer cell - 753787 3.4.21.20 NB-4 cell leukemic cell line 653667 3.4.21.20 neutrophil - 650266, 651320, 652509, 653667, 664269, 664857, 665537, 665619, 665913, 683071, 683354, 683748, 683876, 683957, 684056, 684082, 691240, 694320, 708698, 709353, 709814, 709987, 718414, 732069, 732742, 754328, 755116, 755171 3.4.21.20 neutrophil azurophilic granule 652085 3.4.21.20 neutrophil expression at high levels on the surface of activated human neutrophils in catalytically active but inhibitor-resistant form 683644 3.4.21.20 neutrophil polymorphonuclear cells, enzyme synthesis 683193 3.4.21.20 neutrophil polymorphonuclear leukocyte, in azurophilic granules 651583 3.4.21.20 neutrophil secretion 653069 3.4.21.20 neutrophil synthesis and secretion 683042 3.4.21.20 PBMC cell - 691695 3.4.21.20 PBMC cell peripheral blood mononuclear cell 691629 3.4.21.20 peripheral blood mononuclear cell - 709983, 718285, 752917 3.4.21.20 plasmacytoid dendritic cell - 709987 3.4.21.20 platelet - 652085 3.4.21.20 polymorphonuclear leukocyte - 709987 3.4.21.20 polymorphonuclear neutrophil - 718143 3.4.21.20 RAW-264.7 cell monocyte/macrophage cell line 691629 3.4.21.20 smooth muscle cell - 731354 3.4.21.20 spleen - 36500, 36504, 36505, 717020 3.4.21.20 sputum - 665646, 708698 3.4.21.20 sputum from humans with cystic fibrosis 651182 3.4.21.20 sputum purulent 36511, 36513, 683644 3.4.21.20 synovial fluid of patients with rheumatoid arthritis and osteoarthritis 684056 3.4.21.20 synovial tissue rheumatoid 36508 3.4.21.20 T-lymphocyte - 731354 3.4.21.20 thymic cortical epithelial cell - 709987 3.4.21.20 thymus - 691695 3.4.21.20 U-937 cell - 36523